Fig. 8: A proposed model of the resistance of GSTZ1-deficient cells to sorafenib.
MAA maleylacetoacetate, FAA fumarylacetoacetate, Bru brusatol, ARE anti-oxidation response element, Fer-1 ferrostatin-1, HCC hepatocellular carcinoma.
Fig. 8: A proposed model of the resistance of GSTZ1-deficient cells to sorafenib. | Cell Death & Disease
